Summary: Nineteen identical (monozygotic) and 20 fraternal (dizygotic) sets of twins between 45 and 51 years of age were given nortriptyline orally in doses of 0-2 mg./kg. body weight three times daily for eight days. The steady-state plasma concentrations of nortriptyline were calculated from the mean of the determinations for days 6, 7, and 8. Identical twins, not treated with other drugs, achieved similar steady-state plasma concentrations of nortriptyline in contrast to fraternal twins who were not given other drugs. The intrapair similarity in steadystate plasma concentrations was not found in identical twins simultaneously treated with various drugs during the experiment. Identical and fraternal twins treated with drugs containing barbiturates had considerably lower steady-state plasma concentrations of nortriptyline compared with untreated twins.
It is concluded that most of the variability in nortriptyline steady-state plasma concentration between persons who have not received drugs is genetically determined. Exposure to other drugs also influences the steady-state plasma concentration of nortriptyline, which in a given patient may therefore be determined by a resultant of genetic and environmental factors.
Introduction
It has recently been established that patients who are treated with the same dose of various tricyclic antidepressants such as desipramine (desmethylimipramine) or nortriptyline show great differences in their steady-state plasma levels (Hammer and Sjdqvist, 1967 ; Sjoqvist et al., 1968) . For desipramine (25 mg. t.i.d.) a range between 8 and 295 ng./ml. plasma has been observed (Hammer and Sjdqvist, 1967; Sjoqvist et al., 1968) and for nortriptyline, given in the same dose, steadystate plasma levels have been shown to vary fortyfold between patients (this laboratory, unpublished). Extensive pharmacokinetic investigations led to the suggestion that the steady-state plasma level of these drugs is mainly determined by their rate of metabolism, since only small individual differences were found in the plasma protein binding, degree of absorption, and renal elimination of these compounds in man Sj6qvist et al., 1968 Sj6qvist et al., , 1969 Borga' et al., 1969) .
The metabolism of drugs in man may be influenced by both genetic (Evans, 1968) and environmental factors, such as exposure to other drugs (Levi et al., 1968) and insecticides (Kolmodin et al., 1969 Figure I N(ortriptyline-Alexanderson et al.
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twins who were on treatment with various drugs during the experiment (Fig. 4) . The statistical calculations revealed significant differences in steady-state plasma concentrations of nortriptyline both between individuals within the pairs (F-ratio (M), P<0 0005) and between the pairs (F-ratio (N), 0 01> P>0 005) (Table IV) . Fig. 5 (Fig. 2) . The analysis of variance did not indicate any differences in the steady-state plasma concentrations between individuals within the pairs (F-ratio (B), P>0 05). There were significant differences between the pairs (F-ratio (C) P<0 0005) (Table II) . Dizygotic twins not taking other drugs (Fig. 3 ) showed significant intrapair (F-ratio (G), P<0 0005) and interpair (F-ratio (H), 0 05>P>0 025) differences in steady-state plasma concentrations of nortriptyline (Table III) . Fig. 5 ). The monozygotic twins (code Nos. 73 and 75), both of whom were on drugs containing barbiturates, had similar but comparatively low (17 and 15 ng./ml. respectively) steady-state plasma levels of nortriptyline (Fig. 4) . There was no significant correlation in this study between smoking habits (cigarettes per day' and the steady-state plasma concentration of nortriptyline (Table I (Bernhard and Beer, 1962; Hermann, 1963 ; Yates et al., 1963; Sjoqvist and Borgj, 1969, unpublished) . The renal excretion of unchanged nortriptyline has been shown to account for less than 5% of the daily dose at a steady-state plasma concentration in man (Sjdqvist et al., 1968 (Sjdqvist et al., , 1969 . The interindividual differences in binding of desipramine and nortriptyline to plasma proteins are negligible (Borga et al., 1969) compared with the observed variations in steady-state plasma concentrations. This may not necessarily exclude some interindividual differences in tissue binding. Under steady-state conditions the amount of absorbed drug should be equal to the amount eliminated. The plasma concentration is kept almost constant in equilibrium with the body tissues. For these reasons the steady-state plasma concentration seems to be generally a much more accurate pharmacokinetic value than, for example, the plasma half-life following a single oral dose. The latter value is more dependent on fluctuations in rates of absorption and distribution. If, however, the drug is discontinued after steady-state has been established the plasma half-life will then more accurately reflect the rate of elimination, since the tissues are equilibrated with the drug . Vesell and Page (1968a , 1968b , 1968c reported that the pronounced differences between individuals in antipyrine, phenylbutazone and dicoumarol metabolism are primarily under genetic rather than environmental control, taking the plasma half-life of a single oral dose as an index of drug metabolism.
According to van Rosstim and Tomey (1968) and van Rossum (1968) the steady-state plasma concentration (C) of a drug is directly proportional to the maintenance dose (Q) and half-time for elimination (t O) and is inversely proportional to the dosage interval (At) and the "volume of distribution" (V) as to be expressed mathematically:
C=1-44Q V At van Rossum and Tomey (1968) also reported that this formula is satisfied by the data on steady-state kinetics of desipramine in man obtained in this laboratory (Hammer and Sjdqvist, 1967) .
The volume of distribution (V) is the ratio of the concentration of drug in the body (mg./kg.) to the concentration in plasma (mg./l.) and hence an index of accumulation in body tissues. V is readily computed from the decline in plasma concentrations after parenteral administration of a known amount of drug (Brodie and Reid, 1967) . If the maintenance dose and the dosage interval are kept constant interindividual variations in steady-state plasma concentrations will be due to differences in t i and/or V, provided that absorption of the drug is complete. It will be of interest to try in the future to evaluate the relative importance of both volume of distribution and rate of metabolism in regulating the steady-state plasma concentration of nortriptyline. None of the kinetic values for nortriptyline discussed so far except t j seems to involve active enzymatic processes. The pronounced interindividual differences in steady-state plasma levels of nortriptyline could be explained by corresponding differences in the metabolism of the compound. It may be possible to identify genetic polymorphisms in the activity of enzymes controlling individual chemical biotransformations.
Recent cross-over studies show that psychiatric patients treated with the structurally related compounds nortriptyline and desipramine achieve similar plasma concentrations on both drugs (Hammer et ad., 1967) . Nortriptyline is metabolized by hydroxylation, desmethylaiion, and conjugation with glucuronic acid in the rat (McMahon et at., 1963) and in man, where hydroxylation seems to be the major metabolic pathway (Hammer, and Sjoqviswt, unpublished dlata) .
From extensive animal investigations it is well known that phenobarbitone and other barbiturates may accelerate the metabolism of drugs by increasing the activity of hydroxylating enzymes in liver microsomes (cf. Burns and Conney, 1965) .
In two identical and three fraternal sets of twins one of the sibs respectively was on concomitant treatment with various drugs containing barbiturates. All these individuals had considerably lower steady-state plasma levels of nortriptyline than the untreated control twins. In one monozygotic pair (code Nos. 73 and 75) both individuals were on barbiturate treatment. These twins not only achieved low steady-state levels of nortriptyline (17 and 15 ng./ml. plasma) compared with the total range in steady-state concentrations (8-78 ng./ml. plasma) but they also showed a remarkable intrapair similarity.
So far it is not clarified whether barbiturates or other drugs may interfere with the absorption of tricyclic antidepressants or change their volume of distribution. Regarding the latter, it is possibly relevant that phenobarbitone does not affect the binding of desipramine to plasma proteins (Borga et al.., 1969) . These facts suggest that the steady-state level of nortriptyline is decreased in barbiturate-treated twins owing to induction of microsomal drug-metabolizing enzymes.
Only two individuals asserted exposure to chemical agents at home or at work. These two (code Nos. 13 and 14)-monozygotic " drug-exposed " males-are in close contact with gases and different chemicals in their daily work as welders.
Our data show that, besides genetic factors, concomitant drug exposure is fundamentally important in determining the steadystate plasma levels of nortriptyline. Thus the intrapair similarity in steady-state level of nortriptyline was not found in monozygotic twins who were treated with other drugs during the experiment.
This finding has clinical implications in relation to the extensive drug combinations commonly used in the treatment of psychiatric disorders. Fixed combinations of antidepressants and potential inducers of drug metabolism are often used. Probably drug interactions have not been recognized in clinical psychopharmacology owing to the difficulties in assessing both therapeutic and adverse effects quantitatively. Accumulating evidence indicates that the pharmacological effects of nortriptyline are directly related to its steady-state plasma concentration (Freyschuss et al., 1969, and unpublished data Fig. 2 ), and the condition was thought to be blackwater fever. The patient died eight days later. The rather unusual characters of the case raised some suspicion about the correctness of the diagnosis, and the blood films were sent for confirmation to Drs. N. H. Swellengrebel, R. Geigy, and E. Mudritz, and to one of us (P. C. C. G. 
